Repression of breast cancer cell growth by proteasome inhibitors in vitro: impact of mitogen-activated protein kinase phosphatase 1

No abstract is available for this paper.

• Publication year

  2015

• Venue

  Cancer Biology & Therapy

• Publication date

  2015-04-16

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1080/15384047.2015.1026465PMID 25774547PMCID PMC4622627
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Silencing the mannose 6‐phosphate/IGF‐II receptor differentially affects tumorigenic properties of normal breast epithelial cells

  2013cited by this paper
• Targeting mitogen-activated protein kinase phosphatase-1 (MKP-1): structure-based design of MKP-1 inhibitors and upregulators.

  2012cited by this paper
• Proteasome inhibitors.

  2012cited by this paper
• Sphingosine 1-phosphate induces MKP-1 expression via p38 MAPK- and CREB-mediated pathways in airway smooth muscle cells.

  2012cited by this paper
• MKP-1: a negative feedback effector that represses MAPK-mediated pro-inflammatory signaling pathways and cytokine secretion in human airway smooth muscle cells.

  2012cited by this paper
• Inhibition of tumor cellular proteasome activity by triptolide extracted from the Chinese medicinal plant 'thunder god vine'.

  2011cited by this paper
• Triptolide and its expanding multiple pharmacological functions.

  2011cited by this paper
• Inhibiting eukaryotic transcription. Which compound to choose? How to evaluate its activity?

  2011cited by this paper
• The investigation of Mitogen-Activated Protein kinase Phosphatase-1 as a potential pharmacological target in non-small cell lung carcinomas, assisted by non-invasive molecular imaging

  2010cited by this paper
• The role of MAP kinases and MAP kinase phosphatase-1 in resistance to breast cancer treatment

  2010cited by this paper
• Mitogen-Activated Protein Kinase Phosphatase-1 in Human Breast Cancer Independently Predicts Prognosis and Is Repressed by Doxorubicin

  2009cited by this paper
• Effects of triptolide from Tripterygium wilfordii on ERalpha and p53 expression in two human breast cancer cell lines.

  2009cited by this paper
• Triptolide-induced suppression of phospholipase D expression inhibits proliferation of MDA-MB-231 breast cancer cells

  2009cited by this paper
• Phase I study of bortezomib with weekly paclitaxel in patients with advanced solid tumours.

  2008cited by this paper
• Mechanisms of proteasome inhibitor action and resistance in cancer.

  2008cited by this paper
• A Phase II Study of Single Agent Bortezomib in Patients with Metastatic Breast Cancer: A Single Institution Experience

  2007cited by this paper
• Feedback control of MKP-1 expression by p38.

  2007influential reference
• Mitogen-activated protein kinase phosphatase-1 is a mediator of breast cancer chemoresistance.

  2007influential reference
• Bortezomib (VELCADE) in metastatic breast cancer: pharmacodynamics, biological effects, and prediction of clinical benefits.

  2006cited by this paper
• Proteasome Inhibitors Induce a p38 Mitogen-activated Protein Kinase (MAPK)-dependent Anti-apoptotic Program Involving MAPK Phosphatase-1 and Akt in Models of Breast Cancer

  2006influential reference
• Tristetraprolin regulates Cyclin D1 and c-Myc mRNA stability in response to rapamycin in an Akt-dependent manner via p38 MAPK signaling

  2006influential reference
• Multicenter phase II study of bortezomib in patients with relapsed or refractory mantle cell lymphoma.

  2006cited by this paper
• Bortezomib or high-dose dexamethasone for relapsed multiple myeloma.

  2005cited by this paper
• Glucocorticoid Receptor-induced MAPK Phosphatase-1 (MPK-1) Expression Inhibits Paclitaxel-associated MAPK Activation and Contributes to Breast Cancer Cell Survival*

  2005cited by this paper
• The Role of Mitogen-activated Protein Kinase Phosphatase-1 in the Response of Alveolar Macrophages to Lipopolysaccharide

  2005cited by this paper
• Evidence That Mitogen-Activated Protein Kinase Phosphatase-1 Induction by Proteasome Inhibitors Plays an Antiapoptotic Role

  2004cited by this paper
• Proteasome inhibitors.

  2002cited by this paper
• Restraint of Proinflammatory Cytokine Biosynthesis by Mitogen-Activated Protein Kinase Phosphatase-1 in Lipopolysaccharide-Stimulated Macrophages

  2002cited by this paper
• MKP-1 (3CH134), an immediate early gene product, is a dual specificity phosphatase that dephosphorylates MAP kinase in vivo.

  1993cited by this paper
• Transformation of Human Breast Epithelial Cells by c‐Ha‐ras Oncogene

  1991cited by this paper
• Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10.

  1990cited by this paper
• Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays.

  1983cited by this paper

• Dual-specificity protein phosphatase 1: A potential therapeutic target in cancer

  2025cites this paper
• Dual-specificity phosphatases: therapeutic targets in cancer therapy resistance

  2022cites this paper
• Bortezomib inhibits lung fibrosis and fibroblast activation without proteasome inhibition

  2021cites this paper
• Analysis of Circulating microRNA Signatures and Preeclampsia Development

  2021cites this paper
• Tetranuclear Polypyridylruthenium(II) Complexes as Inhibitors and Down-Regulators of Phosphatase Enzymes

  2017cites this paper
• Cytotoxic effect of triptolide on LPS-treated macrophages through sustained phosphorylation of p38 MAP kinase and apoptosis

  2017cites this paper
• Antiproliferative effects of Bortezomib in endothelial cells transformed by viral G protein-coupled receptor associated to Kaposi's sarcoma.

  2017cites this paper
• Novel Strategies to Improve the Endocrine Therapy of Breast Cancer

  2017cites this paper
• Phosphatases and solid tumors: focus on glioblastoma initiation, progression and recurrences.

  2017cites this paper
• c-Jun N-Terminal Kinase Inactivation by Mitogen-Activated Protein Kinase Phosphatase 1 Determines Resistance to Taxanes and Anthracyclines in Breast Cancer

  2016cites this paper
• Breast cancer cells: Modulation by melatonin and the ubiquitin-proteasome system--a review.

  2015cites this paper